Clinical trial

Contraceptive Hormones, Immunity, and Microbiome Evaluation

NCT03660046

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-12-07

PhaseN/A

Study timeline

Study start (actual)2018-12-07Date precision: day

Registry last updated2024-10-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hormonal Contraceptionunresolved

Interventions

Depot medroxyprogesterone acetate (DMPA)DRUG

Etonogestrel implant (Eng-Implant)DRUG

Levonorgestrel IUD (Lng-IUD)DRUG

Sponsors & collaborators

Emory Universitylead sponsor

National Institutes of Health (NIH)collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

Mapped research locations

AtlantaGeorgia, United States3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03660046 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.